Parents’ experience of childhood atopic eczema in the public health sector of Gauteng

Meintjes, Kaarina Frieda; Nolte, Anna

doi:10.4102/curationis.v38i1.1215

Cited by 13 publications

(10 citation statements)

References 31 publications

(50 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other challenges are more specific to developing countries. Limited/ineffective healthcare systems [59, 87] and a lack of specialists with training in the management of AD [59, 88] are among the major challenges. In addition, regional differences in availability (Table 3) [89–120] present a challenge, as does the cost of AD treatment [121, 122], especially for newer, more effective treatments [123–125].…”

Section: Challenges In Ad Managementmentioning

confidence: 99%

Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review

Carrera¹,

Hammadi

Huang

et al. 2019

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Atopic dermatitis (AD), the leading cause of skin-related burden of disease worldwide, is increasing in prevalence in developing countries of Asia, Africa, Latin America, and the Middle East. Although AD presents similarly across racial and ethnic groups as chronic and relapsing pruritic eczematous lesions, some features of the disease may be more or less prominent in patients with darker skin. Despite a similar presentation, consistent diagnostic criteria and consistent treatment guidelines are lacking. Because of these and other challenges, adherence to treatment guidelines is difficult or impossible. Previous studies have stated that many patients with AD receive ineffective or inappropriate care, such as oral antihistamines, oral corticosteroids, or traditional medicines, if they are treated at all; one study showed that approximately one-third of patients received medical care for their dermatologic condition; of those, almost three-quarters received inappropriate or ineffective treatment. In addition, other challenges endemic to developing countries include cost, access to care, and lack of specialists in AD. Furthermore, most of the available diagnostic criteria and treatment guidelines are based on European and North American populations and few clinical trials report the racial or ethnic makeup of the study population. Drug pharmacokinetics in varying ethnicities and adverse effects in different skin physiologies are areas yet to be explored. The objective of this review is to describe the diagnosis, treatment, and management of AD in developing countries in Asia, Africa, Latin America, and the Middle East; to discuss the differences among the countries; and to establish the unmet needs of patients with AD in them. The unmet medical need for treatment of AD in developing countries can be addressed by continuing to train medical specialists, improve Enhanced Digital Features To view enhanced digital features for this article go to https://doi.org/10.6084/ m9.figshare.9918782.

show abstract

Section: Challenges In Ad Managementmentioning

confidence: 99%

Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review

Carrera¹,

Hammadi

Huang

et al. 2019

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

show abstract

“…QoL data from Africa are limited but have been reported for South Africa and Uganda. A 2015 South African qualitative study involving interviews with ten parents of children aged 0–12 years who have AD helped identify detrimental physical, emotional, and social effects of AD to children and families [ 62 ]. Consistently reported factors with prominent impact on child QoL included physical discomfort from persistent itching and scratching, low self-esteem, and social isolation.…”

Section: Quality Of Lifementioning

confidence: 99%

Understanding the Burden of Atopic Dermatitis in Africa and the Middle East

Al-Afif

Buraik

Buddenkotte

et al. 2019

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Atopic dermatitis (AD) is a common inflammatory skin disease characterized by intensely pruritic lesions. The prevalence of atopic dermatitis is increasing in developing regions, including Africa and the Middle East. However, these regions are underrepresented in the dermatology literature, and a better understanding of the growing burden of atopic dermatitis in Africa and the Middle East is necessary. Herein, we summarize current knowledge on atopic dermatitis epidemiology, disease burden, and treatment options in Africa and the Middle East, highlighting the unmet needs of patients in these regions. With these needs in mind, we provide clinical recommendations for appropriate management of atopic dermatitis in Africa and the Middle East. Funding Pfizer Inc. Plain Language Summary Plain language summary available for this article.

show abstract

“…Studies for eg. in South Africa and Uganda reveals that AD has an impact on physical discomfort, low self-esteem, emotional and social isolation to children and families (25,26).…”

Section: Discussionmentioning

confidence: 99%

Mapping Research Evidence on Children With Atopic Dermatitis and Quality of Life in Sub-saharan Africa: a Scoping Review Protocol

Enbiale¹,

Mosam²,

Wyk³

2021

Preprint

View full text Add to dashboard Cite

Background: Atopic dermatitis (AD) is a chronic, debilitating disease affecting children worldwide. Several studies have explored the disease causes a significant problem leading to a diminished quality of life, for the affected children but systematic evaluation of such studies in Africa is yet to be reported. Therefore, this scoping review aims to map research evidence on children with AD and their quality of life (QoL) in sub-Saharan Africa.Methods: The scoping review will follow the Arksey and O’Mally methodological framework. The electronic databases to be searched will include: PubMed, EBSCOhost (Academic search complete, CINAHL PsycINFO, and Health Sources), Scopus, and Google Scholar for published literature between 2000 and 2021. Only literature written in English will be included. The search strategy for the databases will include keywords, Medical Subject Headings terms and Boolean operators. The reference list of the included sources of evidence, and the WHO website will also be consulted for evidence relating to QoL of children with AD in Sab-Saharan Africa (SSA). Following title searching, two independent reviewers will conduct screening of abstracts and full text articles. Eligibility criteria will guide the screenings. This review will include studies conducted in SSA, publication focusing on quality of life and associated factors of AD in children. Data will be extracted from the included studies, analyzed qualitatively; NVIVO software V.11 will be usedand the emerging themes reported narratively. The mixed-method appraisal tool (MMAT) will be employed for quality appraisal of included studies.Discussion: We look forward to findings of several studies that describe the QoL and associated factors among children with AD and that report on using different diagnostic criteria, severity scaling and QoL measuring scale tools used to ascertain the presence of AD, scale severity of AD and impact of AD on quality of life among children. The study findings will be disseminated through publication in a peer-reviewed journal, peer presentations, and presentations at relevant conferences.

show abstract

Parents’ experience of childhood atopic eczema in the public health sector of Gauteng

Cited by 13 publications

References 31 publications

Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review

Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review

Understanding the Burden of Atopic Dermatitis in Africa and the Middle East

Mapping Research Evidence on Children With Atopic Dermatitis and Quality of Life in Sub-saharan Africa: a Scoping Review Protocol

Contact Info

Product

Resources

About